| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | WORK Medical Technology Group reports Q2 results | 2 | Seeking Alpha | ||
| 16.06. | WORK Medical announces 1-for-100 reverse stock split | 7 | Seeking Alpha | ||
| 16.06. | WORK Medical Technology Group LTD: WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026 | 635 | GlobeNewswire (Europe) | Auckland, New Zealand, June 16, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, today announced... ► Artikel lesen | |
| 05.06. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 03.06. | Work Medical establishes U.S. subsidiary in Nevada | 4 | Investing.com | ||
| 03.06. | WORK Medical Technology Group LTD: WORK Medical Technology Group Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy | 352 | GlobeNewswire (Europe) | Hangzhou, China, June 03, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China today announced the... ► Artikel lesen | |
| WORK MEDICAL TECHNOLOGY GROUP Aktie jetzt für 0€ handeln | |||||
| 27.05. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 6 | SEC Filings | ||
| 14.05. | Morning Market Movers: Robo.ai, Antelope Enterprise Holdings, WORK Medical Technology Group, POET Technologies See Big Swings | 1.192 | AFX News | SAN FRANCISCO (dpa-AFX) - At 8:20 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the... ► Artikel lesen | |
| 13.05. | WORK Medical Technology Group Is Trending Overnight - Here's Why WOK Stock Surged Over 69% In After-Hours Session | 19 | Benzinga.com | ||
| 11.05. | WORK Medical Technology Group LTD: WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the "BioToken" Assetization Model | 123 | GlobeNewswire (Europe) | Hangzhou, China, May 11, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China, through its subsidiaries... ► Artikel lesen | |
| 01.05. | WORK Medical Technology Group LTD: WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper | 1 | GlobeNewswire (USA) | ||
| 15.04. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 27.02. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.12.25 | WORK Medical Technology Group LTD: WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026 | 628 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 29.12.25 | WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer | 359 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 24.12.25 | WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025 | 1.103 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 16.10.25 | WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025 | 368 | GlobeNewswire (Europe) | Hangzhou, China, Oct. 16, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 14.10.25 | WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq | 302 | GlobeNewswire (Europe) | Hangzhou, China, Oct. 14, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 10.10.25 | WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance | 343 | GlobeNewswire (Europe) | Hangzhou, China, Oct. 10, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 24.09.25 | WORK Medical Technology Group Ltd.: WORK Medical enters strategic partnerships in bid to explore RWA initiatives | 1.095 | JCN Newswire | - The medical products maker hopes to leverage RWA technology to transform and leverage its current product infrastructure and budding AI businessHONG KONG, Sept 24, 2025 - (ACN Newswire) - Key Takeaways:-... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,512 | +0,66 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| HIMS & HERS HEALTH | 28,960 | +0,07 % | Hims & Hers Health facing penalties from Visa for credit card disputes - report | ||
| SERNOVA BIOTHERAPEUTICS | 0,069 | +1,46 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| CERENOME | 2,555 | 0,00 % | Plus Therapeutics GAAP EPS of -$1.31 misses by $0.45; reaffirms FY outlook | ||
| HEALWELL AI | 0,487 | -0,81 % | HEALWELL AI: HEALWELL AI's DARWEN AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation | Pentavere advances from winning the 2024 Prix Galien USA Award to competing internationally among Prix Galien winners from around the world, further validating DARWEN AI as a globally recognized... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc. - 8-K, Current Report | ||
| TANDEM DIABETES | 19,100 | 0,00 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,210 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| ORGANON | 11,735 | -0,38 % | Dividendenbekanntmachungen (14.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADM HAMBURG AG DE0007269003 - 13,58 EUR AGCO CORPORATION US0010841023 0,3 USD 0,2602 EUR AGNT INC US30212W1009 0,05 USD 0,0433... ► Artikel lesen | |
| VERU | 2,640 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,510 | -1,40 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| SENSEONICS | 8,250 | -0,60 % | Senseonics sees activist investor take a major stake | ||
| ELEKTA | 5,065 | -0,30 % | Elekta AB: Elekta presents financial targets and detailed outlook ahead of Capital Markets Day | STOCKHOLM - Elekta (EKTA-B.ST) today presents new mid-term financial targets and a more detailed outlook for fiscal year (FY) 2026/2027 ahead of its Capital Markets Day in Stockholm.
Elekta is planning... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,040 | 0,00 % | Tempest Therapeutics, Inc. - S-1, General form for registration of securities | ||
| IMUNON | 1,430 | +2,88 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen |